Moody's Places Hospira's (HSP) Ratings on Review for Upgrade (PFE)
Go back to Moody's Places Hospira's (HSP) Ratings on Review for Upgrade (PFE)| Hospira Inc. (NYSE: HSP) | Delayed: 89.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.95 | 52 Week High | $90.63 | |||
| Open | $3.49 | 52 Week Low | $46.56 | |||
| Day High | $89.95 | P/E | N/A | |||
| Day Low | $89.95 | EPS | $-0.05 | |||
| Volume | 24,251 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 -0.13 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.21 | 52 Week High | $37.39 | |||
| Open | $25.22 | 52 Week Low | $28.25 | |||
| Day High | $25.31 | P/E | 15.20 | |||
| Day Low | $24.96 | EPS | $1.65 | |||
| Volume | 41,061,133 | |||||
